Researchers find new target to sensitize pancreatic tumors to immunotherapy
DPY30 acts as an epigenetic regulator to help pancreatic tumors maintain genomic stability
Targeting DPY30 triggers immune cell infiltration and sensitizes tumors to immunotherapy
DPY30 expression could predict which patients are more likely to benefit from immunotherapy
Therapeutic strategies could combine DPY30 inhibition with immunotherapy to improve patient outcomes
Researchers at The University of Texas MD Anderson Cancer Center...
Study identifies strategy to overcome radiation therapy resistance in lung cancer
These results show how mitochondrial enzyme dihydroorotate dehydrogenase contributes to radiation therapy resistance
Researchers were able to...
Researchers identify blood-based biomarker for cancer risk in people with Lynch Syndrome
Lynch Syndrome (LS) is a hereditary condition involving mutations in DNA mismatch repair genes
Researchers sequenced T cell receptors in blood...
Radiation therapy improves outcomes for 'supermassive’ bile duct tumors
Patient outcomes were significantly better when treated with radiation therapy plus standard-of-care chemotherapy
This type of radiation therapy has only been made possible in the last 10-15 years
Testing did not find significant biological differences between very large tumors and smaller tumors that are commonly treated with radiation
A new study from researchers...
First-in-class radio-theranostic utilizes novel antibody developed at UT MD Anderson
Study details the development of a novel antibody that targets a specific type of B7-H3, a protein overexpressed in many cancers